Susceptibility for relapsing major depressive disorder can be calculated
Novel research approach: Animated debate to be expected
2014-10-22
(Press-News.org) Selver Demic and his colleagues from the Mercator Research Group have set out to find out more about the causes of depression. "Approx. 20 per cent of the population will suffer a de-pressive episode in the course of their lives," says Demic. "This cohort of 20 per cent includes people who will never again experience any problems after that one-time episode is over. The others, however, will suffer repeatedly or chronically under the disorder, despite taking appropriate medication. We want to use our model to explain the occurrence and recurrence rates."
Unfortunate combination of factors
Demic used parameters such as forgetting rate and cognitive bias, as well as the activity levels of the endogenous mood booster serotonin, which are known to be causes of depression. External factors such as family and job situation were likewise considered. Unlike other research projects to date, he integrated all these factors into one single model. His findings were as follows: the observed frequencies could be accounted for only when there are two distinct patient groups. A high-risk group whose parameters are so unfortunately aligned that they will always suffer from recurring depressions. And another group in which depres-sion will only occur by chance.
Different disease states
The scientists also wished to compile a systematic definition for the individual disease states that is based on objective facts. Psychologists and doctors already agreed on different states in the past: the depressive episode, which is diagnosed after characteristic symptoms such as lack of motivation and sadness have lasted for min. 14 days. The recovery phase, which applies when the patient has not presented any symptoms for a period of at least six months. And the remission phase, if the period between two depressive episodes is shorter than six months.
Objective facts instead of intuition
"When assessing which phase the patient is currently undergoing, psychologists and doctors will also always rely on their intuition and experience. Often, it is not clear if a patient is go-ing through the remission or the recovery phase when he shows depressive symptoms for a few days during the six-month period," explains Demic. Consequently, the neuroscientist developed a mathematical model, a so-called finite state machine (FSM). This tool is fed data regarding a patient's state every day. Based on those data and as result of the timecourse, the FSM calculates the disease state that the patient is currently undergoing.
Welcoming debates
"Our approach to understand depression is entirely novel," says Demic. "Therefore, we expect animated debates with doctors, psychologists and other scientists. What's important is that we have demonstrated the potential computer-based models offer with regard to research into depression."
About the Mercator Research Group "Structure of Memory"
In a joined project with the Mercator Foundation, Ruhr-Universität Bochum has set up the Mercator Research Group "Structure of Memory". Experimental and theoretical neuroscientists as well as philosophers make up the team, which has been studying episodic and semantic memory processes and the way they relate to other cognitive functions since 2010.
INFORMATION:
ELSE PRESS RELEASES FROM THIS DATE:
2014-10-22
INDIANAPOLIS -- Indiana is at the forefront of providing mental health screening and services to juvenile offenders, but more efforts are needed to improve the services provided to detained youths, according to Indiana University School of Medicine research findings published in the October issue of the American Journal of Public Health.
"A Statewide Collaboration to Initiate Mental Health Screening and Assess Services for Indiana Detained Youths" reviewed 25,265 detention visits of 15,461 youths occurring in 2008 to 2011. The youths were incarcerated in 16 detention ...
2014-10-22
This news release is available in German. An international team of scientists have become the first ever researchers to successfully reach temperatures below minus 272.15 degrees Celsius – only just above absolute zero – using magnetic molecules. The physicists and chemists are presenting their new investigation today (22 October 2014) in the scientific journal Nature Communications. It was developed by six scientists from Bielefeld University, the University of Manchester (Great Britain), and the Universidad de Zaragoza (Spain).
Scientists usually express ...
2014-10-22
Though most NCAA colleges and universities have created programs to help athletes deal with concussions, a new Harvard study has found that, when it comes to specific components of those plans, many institutions still lag behind accepted standards.
The study, the first-ever comprehensive examination of how colleges and universities have complied with the Concussion Policy and Legislation adopted by the NCAA in 2010, is based on the results of a survey sent to all 1,066 NCAA member institutions. Of those institutions, 907 schools responded.
The results, according to ...
2014-10-22
BOSTON – It is an intricate network of activity that enables breast cancer cells to move from the primary breast tumor and set up new growths in other parts of the body, a process known as metastasis.
Now a research team led by investigators at Beth Israel Deaconess Medical Center (BIDMC) has identified an unexpected link between a transcription factor known to regulate speech and language development and metastatic colonization of breast cancer.
Currently described online in Cell Stem Cell, the new findings demonstrate that, when silenced, the FOXP2 transcription ...
2014-10-22
October 22, 2014 – In contrast to national trends, a study performed at Alabama's largest hospital finds no racial difference in the risk of pregnancy-related death between African American and Caucasian women, reports the November issue of Anesthesia & Analgesia.
However, the results show a significant increase in maternal mortality for women who live greater distances from the hospital, according to the study Dr Michael Froelich of University of Alabama at Birmingham (UAB) and colleagues. The findings point to differences in health care access as a possible explanation ...
2014-10-22
A large international clinical trial has shed new light on the effectiveness of current hospital protocols for managing blood pressure in stroke patients.
The two-part ENOS trial (Efficacy of Nitric Oxide in Stroke,) was carried out at The University of Nottingham in collaboration with 23 countries to try to solve two major conundrums faced by doctors when treating people who have suffered a stroke — should blood pressure be lowered using medicated skin patches, and should existing blood pressure medication be stopped or continued after a stroke?
The results of ...
2014-10-22
PITTSBURGH, Oct. 22, 2014 – Children with autism spectrum disorder (ASD) were more likely to have been exposed to higher levels of certain air toxics during their mothers' pregnancies and the first two years of life compared to children without the condition, according to the preliminary findings of a University of Pittsburgh Graduate School of Public Health investigation of children in southwestern Pennsylvania.
This research, funded by The Heinz Endowments, will be presented today at the American Association for Aerosol Research annual meeting in Orlando, Fla. ...
2014-10-22
A painful inflamed lesion on the oral mucosa, which often seems to be burning at the periphery: every third individual has at one point had such a lesion—an aphthous ulcer. Often they resolve after a brief period of time. In 2% to 10% of patients these lesions are recurrent and require medical treatment. Unfortunately, as Andreas Altenberg and co-authors point out in a current review on the therapy of aphthous ulcers (Dtsch Arztebl Int 2014; 111: 665–73), the etiology of these lesions is unclear. Thus aphthous ulcers can only be treated symptomatically.
Even ...
2014-10-22
Boston, MA – A research team led by Brigham and Women's Hospital (BWH) has developed and tested a novel nanoparticle platform that efficiently delivers clinically important proteins in vivo in initial proof-of-concept tests. Nanoparticles, which are particles measuring nanometers in size, hold promise for a range of applications, including human therapeutics. The key advantage of the new platform, known as a thermosponge nanoparticle, is that it eliminates the need for harsh solvents, which can damage the very molecules the particles are designed to carry.
The study ...
2014-10-22
(Sacramento, CA): Broad-spectrum prevention that can simultaneously prevent unintended pregnancy along with STIs, including HIV, is on the horizon say experts in a special supplement of the BJOG: An International Journal of Obstetrics and Gynaecology. The issue features an international assemblage of researchers, funders, developers and advocates who identify the pressing global health rationale for MPTs and present new research and strategies for making the go/no-go funding and research decisions that shape the field.
The invited guest editor for the supplement is Dr. ...
LAST 30 PRESS RELEASES:
[Press-News.org] Susceptibility for relapsing major depressive disorder can be calculated
Novel research approach: Animated debate to be expected